Back to AssetMark, Inc. AssetMark, Inc.

ARWR

21 quarters

Position history for AssetMark, Inc.AssetMark, Inc.'s holdings in Arrowhead Pharmaceuticals, Inc.

Yes. AssetMark holds 2,228 shares of ARWR (Arrowhead Pharmaceuticals), worth $145,823, as of its Q3 2026 13F filing. It reduced the position by 22 shares (-1.0%) from Q2 2026. AssetMark has held ARWR since Q3 2025, across 5 quarterly 13F filings.

Current Value

$145,823

Current Shares

2,228

Total Value Change

+$144,823

Total Shares Change

+2,195

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
2,228
-1.0%
$145,8230.0%$65.45
0
2026-Q2
Decreased
2,250
-8.9%
$183,3980.0%$81.51
0
2026-Q1
Increased
2,470
+896.0%
$154,8690.0%$62.70
36
2025-Q4
Increased
248
+675.0%
$16,4650.0%$66.39
20
2025-Q3
New
32
-
$1,1040.0%$34.49
17
2025-Q1
Exited
0
-100.0%
$00.0%$12.74
0
2024-Q4
New
6
-
$1130.0%$18.80
17
2023-Q3
Exited
0
-100.0%
$00.0%$26.87
0
2023-Q2
Increased
58,697
+3.8%
$2.1M0.0%$35.66
27
2023-Q1
Decreased
56,549
-32.6%
$1.4M0.0%$25.40
0
2022-Q4
Increased
83,965
+6.5%
$3.4M0.0%$40.56
28
2022-Q3
Increased
78,877
+13.6%
$2.6M0.0%$33.05
30
2022-Q2
Increased
69,456
+33.6%
$2.4M0.0%$35.21
34
2022-Q1
Increased
51,969
+86.9%
$2.4M0.0%$45.99
41
2021-Q4
Increased
27,805
+1962.7%
$1.8M0.0%$66.30
42
2021-Q3
New
1,348
-
$84,0000.0%$62.43
30
2020-Q3
Exited
0
-100.0%
$00.0%$43.06
0
2020-Q2
Unchanged
11
0.0%
$00.0%$43.19
0
2020-Q1
Decreased
11
-66.7%
$00.0%$28.77
0
2019-Q4
Unchanged
33
0.0%
$2,0000.0%$63.43
0
2019-Q3
New
33
-
$1,0000.0%$28.18
17

Other major holders of ARWR: BlackRock, Inc., Vanguard Group Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used